Weaver Capital Management LLC lessened its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.0% in the 3rd quarter ...

GAM Holding AG raised its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 55.3% in the third quarter, ...

Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily ...

The company is suing some online vendors and medical spas for selling copycats of a weight loss and diabetes drug.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

As an investor in Eli Lilly stock, I'm encouraged by the company's forward thinking. Not only is management making moves to ...

In this piece, we will look at where Eli Lilly and Company (NYSE:LLY) sits on the fund managers’ radar. The surge in interest surrounding artificial intelligence has meant that […] Lilly (LLY ...

Eli Lilly has filed three new separate lawsuits accusing vendors and a medical spa of selling knock-off versions of their ...

Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other Most Promising Growth Stock According to Hedge Funds. Investors had been anxiously ...

Eli Lilly (LLY) is suing medical spas and online vendors who claim their products contain the main ingredients of GLP-1 weight-loss drug Zepbound, according to Reuters. Lastly, Bloomberg reports that ...